Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Karen R, Rabin"'
Autor:
Jacob J. Junco, Max Rochette, Michelle Alozie, Raushan Rashid, Maci Terrell, Barry Zorman, Pavel Sumazin, Lauren Rowland, Gino Dettorre, Reid T. Powell, Clifford C. Stephan, Peter J. Davies, Margarita Martinez-Moczygemba, Jun J. Yang, Karen R. Rabin
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/590d5e704bc84918a4652e95e30f9135
Autor:
Caitlin W. Elgarten, John A. Kairalla, Joel C. Thompson, Tamara P. Miller, Cindy Wang, Susan Conway, Mignon L. Loh, Elizabeth A. Raetz, Sumit Gupta, Rachel E. Rau, Anne Angiolillo, Karen R. Rabin, Sarah Alexander
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 745-750 (2023)
Abstract Hematologic malignancy is a risk factor for severe coronavirus disease 2019 (COVID‐19) in adults; however, data specific to children with leukemia are limited. High‐quality infectious adverse event data from the ongoing Children's Oncolo
Externí odkaz:
https://doaj.org/article/57edae85d0ba4b3fbd3daa30c6697185
Autor:
André Baruchel, Jean-Pierre Bourquin, John Crispino, Sergi Cuartero, Henrik Hasle, Johann Hitzler, Jan-Henning Klusmann, Shai Izraeli, Andrew A. Lane, Sébastien Malinge, Karen R. Rabin, Irene Roberts, Sandra Ryeom, Sarah K. Tasian, Elvin Wagenblast
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Children with Down syndrome (DS, trisomy 21) are at a significantly higher risk of developing acute leukemia compared to the overall population. Many studies investigating the link between trisomy 21 and leukemia initiation and progression have been
Externí odkaz:
https://doaj.org/article/dcd8614ac85d403187af8360be79dab7
Autor:
Jeremy M. Schraw, J. P. Woodhouse, Melanie B. Bernhardt, Olga A. Taylor, Terzah M. Horton, Michael E. Scheurer, M. Fatih Okcu, Karen R. Rabin, Philip J. Lupo, Austin L. Brown
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Metabolomics may shed light on treatment response in childhood acute lymphoblastic leukemia (ALL), however, most assessments have analyzed bone marrow or cerebrospinal fluid (CSF), which are not collected during all phases of therapy. Blood
Externí odkaz:
https://doaj.org/article/8c04e83546a4413485aff2fad63ba637
Autor:
Carol Fries, Lik Wee Lee, Meenakshi Devidas, Yunfeng Dai, Karen R. Rabin, Sumit Gupta, Mignon L. Loh, Ilan R Kirsch, Brent Wood, Rachel E. Rau
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/47b98bb671bb4f43af20f4eac1eaf36f
Autor:
Joanna S. Yi, Tiffany M. Chambers, Kelly D. Getz, Tamara P. Miller, Evanette Burrows, Marla H. Daves, Philip J. Lupo, Michael E. Scheurer, Richard Aplenc, Karen R. Rabin, Maria M. Gramatges
Publikováno v:
Haematologica, Vol 107, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/9baa58778dc147a9b6f2497133e871f2
Autor:
Jeremy M. Schraw, Jacob J. Junco, Austin L. Brown, Michael E. Scheurer, Karen R. Rabin, Philip J. Lupo
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 49-57 (2019)
Background: End-induction minimal residual disease (MRD) is the strongest predictor of relapse in paediatric acute lymphoblastic leukaemia (ALL), but an understanding of the biological pathways underlying early treatment response remains elusive. We
Externí odkaz:
https://doaj.org/article/25ff8e1b29f44a54bd92a1e59f43849d
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0244863 (2021)
Children with Down syndrome have an approximately 10-fold increased risk of developing acute lymphoblastic leukemia and this risk is influenced by inherited genetic variation. Genome-wide association studies have identified IKZF1 as a strong acute ly
Externí odkaz:
https://doaj.org/article/cb79d0cea4ee4644865f6af9b56eaae2
Autor:
Mark Zobeck, M. Brooke Bernhardt, Kala Y. Kamdar, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:205-214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e345544e31effee151f88aaebf535ad9
https://doi.org/10.1002/phar.2779
https://doi.org/10.1002/phar.2779
Publikováno v:
Blood Advances. 7:422-435
Novel drugs are needed to increase treatment response in children with high-risk T-cell acute lymphoblastic leukemia (T-ALL). Following up on our previous report on the activation of the MAP2K7-JNK pathway in pediatric T-ALL, here we demonstrate that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353929ab15bd6261e7817605198eccd8
https://doi.org/10.1182/bloodadvances.2022008548
https://doi.org/10.1182/bloodadvances.2022008548